ASLAN, A. T. Et Al. 2021. Comparison of teicoplanin versus vancomycin in combination with piperacillin-tazobactam or meropenem for the risk of acute kidney injury. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.40, no.9 , 1953-1961.

ASLAN, A. T., Pashayev, T., DAĞ, O., & AKOVA, M., (2021). Comparison of teicoplanin versus vancomycin in combination with piperacillin-tazobactam or meropenem for the risk of acute kidney injury. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.40, no.9, 1953-1961.

ASLAN, ABDULLAH Et Al. "Comparison of teicoplanin versus vancomycin in combination with piperacillin-tazobactam or meropenem for the risk of acute kidney injury," EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.40, no.9, 1953-1961, 2021

ASLAN, ABDULLAH T. Et Al. "Comparison of teicoplanin versus vancomycin in combination with piperacillin-tazobactam or meropenem for the risk of acute kidney injury." EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.40, no.9, pp.1953-1961, 2021

ASLAN, A. T. Et Al. (2021) . "Comparison of teicoplanin versus vancomycin in combination with piperacillin-tazobactam or meropenem for the risk of acute kidney injury." EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.40, no.9, pp.1953-1961.

@article{article, author={ABDULLAH TARIK ASLAN Et Al. }, title={Comparison of teicoplanin versus vancomycin in combination with piperacillin-tazobactam or meropenem for the risk of acute kidney injury}, journal={EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES}, year=2021, pages={1953-1961} }